Ceryvyn Therapeutics Limited
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-5.7M | $-5.7M | $2.5K | $732.7K |
| FY2021 | $-45.5M | $-45.6M | $12.7K | $3.9M |
| FY2022 | $-71.3M | $-71.4M | $16.9K | $5.3M |
| FY2023 | $-120.6M | $-120.6M | $22.0K | $5.8M |
| FY2024 | $-161.0M | $-161.0M | $33.0K | $5.1M |